Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
FDC Ltd.
₹383
Invest in FDC with up to 2.86x margin.
Trade with MTF₹355.35
₹383.00
₹357.55
₹527.80
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 457.94 | 461.74 | 642.28 | 482 | 458.86 |
| Operating Expense | 408.33 | 426.85 | 500.94 | 429.18 | 412.92 |
| Operating Profit | 49.61 | 34.89 | 141.34 | 52.83 | 45.95 |
| Depreciation | 14.75 | 15.17 | 14.87 | 15.53 | 13.32 |
| Interest | 1.12 | 1.15 | 1.16 | 1.18 | 0.94 |
| Tax | 7.84 | 10.02 | 38.69 | 19.33 | 13.87 |
| Net Profit | 27.19 | 29.48 | 122.19 | 48.22 | 36.45 |
Research Type
Equity , Long Term
Buy Range
₹485 - ₹496
Target Price
₹589
Stop Loss
-
Target Date
7 Apr 26
Potential Returns
21.44 %
₹383.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 69.7 | 69.7 | 69.7 | 69.7 | 69.7 | 69.7 |
| FII | 2.6 | 2.7 | 2.6 | 2.4 | 2.4 | 2.3 |
| DII | 6 | 6.1 | 6.3 | 7.2 | 6.8 | 6.3 |
| Public | 21.7 | 21.6 | 21.4 | 20.8 | 21.1 | 21.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 31.62 K | 54.3 K | 58.23% |
| Week | 29.84 K | 54.93 K | 54.32% |
| 1 Month | 41.14 K | 77.82 K | 52.87% |
| 6 Month | 68.78 K | 1.53 L | 45.04% |
Positive Breakout Second Resistance ( LTP > R2)
Companies with no Debt
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
High Volume, High Gain
Top Gainers
Volume Shockers
Insiders bought stocks
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Feb, 2026 | 5 | INTERIM | 11 Feb, 2026 | Equity Share |
| 22 Nov, 2024 | 5 | INTERIM | 22 Nov, 2024 | Equity Share |
| 19 Mar, 2020 | 0.8 | INTERIM | 21 Mar, 2020 | Equity Share |
| 08 Aug, 2017 | 2.25 | FINAL | Equity Share | |
| 17 Mar, 2016 | 2.25 | INTERIM | 19 Mar, 2016 | Equity Share |
| 23 Sep, 2015 | 2.25 | FINAL | Equity Share | |
| 28 Jul, 2014 | 2.25 | FINAL | Equity Share | |
| 20 Aug, 2013 | 2.25 | FINAL | Equity Share | |
| 06 Aug, 2012 | 2 | FINAL | Equity Share | |
| 13 Sep, 2011 | 2 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,577 | ₹628.95 | ₹780 | ₹968 | ₹1,320 | ₹4,075 |
| % Change | 3.47% | -5.40% | -0.01% | 2.83% | 3.96% | 0.75% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹2,169.86 | ₹1,419.33 | ₹798.10 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹332.94 | ₹20.10 | ₹217.90 |
| PE TTM | - | - | 62.20 | 61.50 | 754.90 | 43.10 |
| 1 Year Return | 48.29 | 6.51 | 60.63 | 37.17 | 3.9 | -12.48 |
| ROCE | 30.24 | 34.78 | 34.76 | 12.51 | 3.26 | - |
Akums Drugs & Pharmaceuticals Ltd.
₹ 474.00
-0.91%
Blue Jet Healthcare Ltd
₹ 391.40
+9.99%
Concord Biotech Ltd.
₹ 1103.00
+0.46%
Aarti Pharmalabs Ltd.
₹ 687.60
-1.60%
Supriya Lifescience Ltd.
₹ 670.00
-1.17%
Acutaas Chemicals Ltd.
₹ 2138.50
+1.52%
Alivus Life Sciences Ltd.
₹ 901.15
-1.08%
Cohance Lifesciences Ltd.
₹ 315.10
+3.18%
Eris Lifesciences Ltd.
₹ 1358.00
+1.16%
Syngene International Ltd.
₹ 448.60
+1.33%
Alembic Pharmaceuticals Ltd.
₹ 774.90
+1.55%
Strides Pharma Science Ltd.
₹ 872.90
+0.37%
Granules India Ltd.
₹ 598.00
-0.18%
Shilpa Medicare Ltd.
₹ 329.00
+1.29%
Jubilant Pharmova Ltd.
₹ 900.00
+3.15%
Natco Pharma Ltd.
₹ 886.00
-0.64%
Caplin Point Laboratories Ltd.
₹ 1739.00
+2.77%
Neuland Laboratories Ltd.
₹ 13507.00
+6.88%
Marksans Pharma Ltd.
₹ 179.32
+0.53%
Sanofi India Ltd.
₹ 4080.00
+1.34%
Procter & Gamble Health Ltd.
₹ 5080.00
+1.21%
Jeena Sikho Lifecare Ltd.
₹ 674.90
-2.16%
By signing up I certify terms, conditions & privacy policy